An injectable, leadless bioelectronic interface for battery-free wireless peripheral neuromodulation
Science Advances · 12.06.2026 · 12 (24)
DOI: 10.1126/sciadv.aeg1437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 12.06.2026. Verfasst von Mohamed Elsherif und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Engineering, New York University (NYU) Abu Dhabi, Abu Dhabi 129188, UAE. Hauptthemen laut MEDLINE: Wireless Technology. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: New York University Abu Dhabi, Center for Translational Medical Devices.
Abstract (Originalsprache)
Injectable bioelectronics offer a minimally invasive approach to peripheral nerve stimulation but remain limited by onboard energy storage and fragile leads. Here, we present SEED, a leadless, battery-free bioelectronic interface engineered for percutaneous delivery through a standard 14-gauge needle. SEED (Stimulating Electrode for Electroceutical Delivery) operates in the magnetoquasistatic regime using low-frequency (65 kilohertz) resonant inductive coupling, externalizing waveform generation and control, enabling programmable neuromodulation without onboard active electronics. A spiral-helix electrode geometry promotes longitudinal nerve engagement while limiting off-target field spread. Benchtop and ex vivo characterization demonstrates precise, programmable control of stimulation frequency, pulse width, and amplitude under physiologically relevant conditions. In vivo validation in a rat sciatic nerve model confirms frequency-locked motor responses and graded neural recruitment following percutaneous deployment. SEED exhibits strong radiopacity and acoustic contrast, supporting compatibility with ultrasound and computed tomography for image-guided neuromodulation. This platform provides a scalable pathway toward minimally invasive bioelectronic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Engineering, New York University (NYU) Abu Dhabi, Abu Dhabi 129188, UAE.
- Otolaryngology Department, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
- Tandon School of Engineering, NYU, New York, NY 11201, USA.
- Digestive Diseases Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
- Grossman School of Medicine and NYU Langone Health, NYU, New York, NY 11201, USA.
ORCID-Profile: Mohamed Elsherif, Salma Mansour, Zhansaya Makhambetova, Batoul Khlaifat, Sohmyung Ha, Juan S Barajas-Gamboa, Carlos M Abril Vega, Khalil B Ramadi
Förderung
- New York University Abu Dhabi
- Center for Translational Medical Devices
Zitieren
APA
Elsherif, M., Mansour, S., Makhambetova, Z., Aldhanhani, F., Khlaifat, B., Elbeh, M., Rachim, V. P., Ha, S., Abada, H., Barajas-Gamboa, J. S., Abril Vega, C. M., & Ramadi, K. B. (2026). An injectable, leadless bioelectronic interface for battery-free wireless peripheral neuromodulation. Science Advances, 12(24). https://doi.org/10.1126/sciadv.aeg1437
Vancouver
Elsherif M, Mansour S, Makhambetova Z, Aldhanhani F, Khlaifat B, Elbeh M, et al. An injectable, leadless bioelectronic interface for battery-free wireless peripheral neuromodulation. Science Advances. 2026;12(24). doi:10.1126/sciadv.aeg1437
BibTeX
@article{Elsherif2026,
author = {Elsherif, Mohamed and Mansour, Salma and Makhambetova, Zhansaya and Aldhanhani, Fotoon and Khlaifat, Batoul and Elbeh, Mahmoud and Rachim, Vega Pradana and Ha, Sohmyung and Abada, Hicham and Barajas-Gamboa, Juan S and Abril Vega, Carlos M and Ramadi, Khalil B},
title = {An injectable, leadless bioelectronic interface for battery-free wireless peripheral neuromodulation},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {24},
doi = {10.1126/sciadv.aeg1437}
}
EUVIMED